Innoviva Inc (INVA) — Free Cash Flow Yield
Biotech & Pharma
| Metric | Value |
|---|---|
| FCF Yield | 12.7% |
| Biotech & Pharma Sector Avg FCF Yield | 16.3% |
| Annual Free Cash Flow | $189M |
| Market Cap | $1.5B |
| P/E Ratio | 10.1x |
Innoviva Inc's FCF yield of 12.7% is below the Biotech & Pharma sector average (16.3%).
Frequently Asked Questions
What is Innoviva Inc's (INVA) free cash flow yield?
Innoviva Inc's (INVA) free cash flow yield is 12.7%. That is below the Biotech & Pharma sector average (16.3%).
Is INVA's free cash flow yield good?
At 12.7%, INVA's free cash flow yield is considered excellent — yields above 10% are generally excellent, 7–10% good, 4–7% fair, and below 4% weak, though context varies by sector and growth stage.
How much free cash flow does Innoviva Inc generate?
Innoviva Inc generated $189M in free cash flow, against a market cap of $1.5B.
How is free cash flow yield calculated?
Free cash flow yield = (Free Cash Flow ÷ Market Capitalization) × 100%. Free cash flow equals operating cash flow minus capital expenditures.
Data from public filings. Not investment advice. Calculate your own FCF yield →